Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA’s Califf: We Don’t Need Much Help From Congress On Rare Diseases
Mar 01 2024
•
By
Derrick Gingery
Califf said the FDA should be making measurable progress on rare disease treatment approvals. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Rare Diseases
More from Pink Sheet